<?xml version="1.0" encoding="UTF-8"?>
<p>Of the primary case-patients, 245 (95.7%) had received AV treatment (of whom 116/118 with information had received oseltamivir). Among treated case-patients, 104 (42.4%) had started treatment 
 <underline>&lt;</underline>48 hours of disease onset, with median time to AV treatment of 3 days (IQR 1â€“5).
</p>
